Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Block vs EBP for PDPH
NCT03112720Phase 3Terminated
- Sponsor
- Rutgers University
- Start
- Sep 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in post-dural puncture headache (PDPH), sponsored by Rutgers University. Started Sep 2016; status: terminated.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT03112720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112720.